Synopsis: In the pivotal Phase 3 TRANSFORM trial, single infusion of Breyanzi significantly outperformed the nearly 30-year standard of care with median…
Tag:
Bristol Myers Squibb
-
-
AgrochemicalsBristol Myers Squibb
Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another JAK drug, exec says
by adminby adminSummary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…